Celcuity announces $400M convertible notes offering
Source: SeekingAlpha
2026-06-03 07:41:26 ET
More on Celcuity
- Celcuity Inc. (CELC) Discusses VIKTORIA-1 Trial Results for PIK3CA Mutant Advanced Breast Cancer and Gedatolisib Efficacy Transcript
- Celcuity: Approaching An Inflection Point With Gedatolisib
- Celcuity Inc. (CELC) Q1 2026 Earnings Call Transcript
- These 10 mid-cap U.S. healthcare companies carry the market's most expensive valuations
- Celcuity falls after detailed late-stage trial data for breast cancer drug
Read the full article on Seeking Alpha
For further details see:
Celcuity announces $400M convertible notes offering
Celcuity Inc.
NASDAQ: CELC
CELC Trading
0.25% G/L:
$88.60 Last:
603,283 Volume:
$88.58 Open:
CELC Latest News
June 03, 2026 10:13:20 pm
Celcuity Inc. Announces Pricing of Upsized Public Offering of 0.250% Convertible Senior Notes Due 2032
June 03, 2026 07:19:12 am
Celcuity Inc. Announces Public Offering of Convertible Senior Notes Due 2032
$4,814,524,499
28,498,468
0.19%
68
N/A
Biotechnology & Life Sciences
Healthcare
US
Minneapolis
